8Daria Zorzi M.D.,John T. Mullen M.D.,Eddie K. Abdalla M.D.,Timothy M. Pawlik M.D., M.P.H.,Axel Andres M.D.,Andrea Muratore M.D.,Steven A. Curley M.D.,Gilles Mentha M.D.,Lorenzo Capussotti M.D.,Jean-Nicolas Vauthey M.D.. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases[J] 2006,Journal of Gastrointestinal Surgery(1):86～94
9Thomas Makatsoris MD,Haralabos P. Kalofonos,Gerasimos Aravantinos,Christos Papadimitriou,Efstathios Kastritis,Sotirios K. Rigatos,Nikolaos Xiros,Theodore Petsas,Theofanis Economopoulos,Athanassios K. Sakadamis,George Fountzilas. A phase II study of capecitabine plus oxaliplatin (XELOX)[J] 2005,International Journal of Gastrointestinal Cancer(2):103～109
10Ronald P. DeMatteo M.D.,Carvn Palese B.S.,William R. Janmgin M.D.,Ruth L. Sim B.A.,Leslie H. Blumgart M.D.,Yieman Fong M.D.. Anatomie segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases[J] 2000,Journal of Gastrointestinal Surgery(2):178～184
6Kitadai Y, Radinsky R, Bucana CD,et al.Regulation of carcinoem- bryonic antigen expression in human colon carcinoma cells by the organ microenvironment[ J ].Am J Pathol, 1996,149(4) : 1157-1166.
7Takano S, Kato J, Yamamoto H, et al. Identification of risk factors for lymph node metastasis of colorectal cancer [J].Hepatogastroenterolo- gy, 2007,54( 75 ) : 746-750.
8Davies M, Arumugam PJ, Shah VI, et al. The clinical significance of lymph node micrometastasis in stage I and stage II colorectal cancer[J]. Clin Transl Oncol, 2008, 10(3): 175-179.
9Yeatman TJ,Kimura AK,Copeland EM,et al.Rapid analysis of car- cinoembryonic antigen levels in gallbladder bile.Identification of patients at high risk of colorectal liver metastasis[J].Ann Surg, 1991,213(2) : 113-117.
